Survival of Mammalian Cells Exposed to Ultrahigh Dose Rates from a Laser-produced Plasma X-ray Source
Affiliations
Purpose: To determine whether intense laser-produced x rays have an increased radiation hazard.
Materials And Methods: Mammalian cells were exposed to x rays from a laser-produced plasma that produced ultrahigh peak absorbed dose rates, up to a factor of 10(10) higher than those produced by conventional x rays used in imaging. The cell survival was studied as a function of the absorbed dose. The survival of mammalian cells exposed to high peak absorbed dose rates with laser-produced x rays was compared with the survival of cells exposed to standard absorbed dose rates with conventional x-ray sources. Comparative survival studies were performed by using a conventional x-ray tube and a cobalt 60 source. The absorbed doses in the irradiation field were measured with thermoluminescent dosimeters.
Results: Cell survival following irradiation by filtered, laser-produced x rays with a high dose rate was not markedly different from the survival following irradiation by conventional sources. There was, however, a notable difference between the survival after exposure to filtered, laser-produced x rays and the survival after exposure to unfiltered laser-produced x rays.
Conclusion: Exposure to filtered, laser-produced x rays with a high dose rate does not lead to increased harm to mammalian cells exposed in vitro compared with the harm from exposure to x rays from conventional sources, which indicates that the use of high-power laser facilities for medical imaging is justified.
Emergence of FLASH‑radiotherapy across the last 50 years (Review).
Li M, Zhou S, Dong G, Wang C Oncol Lett. 2024; 28(6):602.
PMID: 39493433 PMC: 11529378. DOI: 10.3892/ol.2024.14735.
Resonantly Enhanced Difference-Frequency Generation in the Core X-ray Absorption of Molecules.
Serrat C J Phys Chem A. 2021; 125(51):10706-10710.
PMID: 34910497 PMC: 8724795. DOI: 10.1021/acs.jpca.1c06950.
Biological Benefits of Ultra-high Dose Rate FLASH Radiotherapy: Sleeping Beauty Awoken.
Vozenin M, Hendry J, Limoli C Clin Oncol (R Coll Radiol). 2019; 31(7):407-415.
PMID: 31010708 PMC: 6850216. DOI: 10.1016/j.clon.2019.04.001.
Laschinsky L, Karsch L, Lessmann E, Oppelt M, Pawelke J, Richter C Radiat Environ Biophys. 2016; 55(3):381-91.
PMID: 27193178 DOI: 10.1007/s00411-016-0652-7.
Xiao Y, Kry S, Popple R, Yorke E, Papanikolaou N, Stathakis S J Appl Clin Med Phys. 2015; 16(3):5219.
PMID: 26103482 PMC: 5690108. DOI: 10.1120/jacmp.v16i3.5219.